Genetic variants of TSLP and asthma in an admixed urban population
- PMID: 21966427
- PMCID: PMC3178593
- DOI: 10.1371/journal.pone.0025099
Genetic variants of TSLP and asthma in an admixed urban population
Abstract
Background: Thymic stromal lymphopoietin (TSLP), an IL7-like cytokine produced by bronchial epithelial cells is upregulated in asthma and induces dendritic cell maturation supporting a Th2 response. Environmental pollutants, including tobacco smoke and diesel exhaust particles upregulate TSLP suggesting that TSLP may be an interface between environmental pollution and immune responses in asthma. Since asthma is prevalent in urban communities, variants in the TSLP gene may be important in asthma susceptibility in these populations.
Objectives: To determine whether genetic variants in TSLP are associated with asthma in an urban admixed population. METHODOLOGY AND MAIN RESULTS: Ten tag-SNPs in the TSLP gene were analyzed for association with asthma using 387 clinically diagnosed asthmatic cases and 212 healthy controls from an urban admixed population. One SNP (rs1898671) showed nominally significant association with asthma (odds ratio (OR) = 1.50; 95% confidence interval (95% CI): 1.09-2.05, p = 0.01) after adjusting for age, BMI, income, education and population stratification. Association results were consistent using two different approaches to adjust for population stratification. When stratified by smoking status, the same SNP showed a significantly increased risk associated with asthma in ex-smokers (OR = 2.00, 95% CI: 1.04-3.83, p = 0.04) but not significant in never-smokers (OR = 1.34; 95% CI: 0.93-1.94, p = 0.11). Haplotype-specific score test indicated that an elevated risk for asthma was associated with a specific haplotype of TSLP involving SNP rs1898671 (OR = 1.58, 95% CI: 1.10-2.27, p = 0.01). Association of this SNP with asthma was confirmed in an independent large population-based cohort consortium study (OR = 1.15, 95% CI: 1.07-1.23, p = 0.0003) and the results stratified by smoking status were also validated (ex-smokers: OR = 1.21, 95% CI: 1.08-1.34, p = 0.003; never-smokers: OR = 1.06, 95% CI: 0.94-1.17, p = 0.33).
Conclusions: Genetic variants in TSLP may contribute to asthma susceptibility in admixed urban populations with a gene and environment interaction.
Trial registration: ClinicalTrials.gov NCT00212537.
Conflict of interest statement
Figures
References
-
- Saxon A, Diaz-Sanchez D. Air pollution and allergy: you are what you breathe. Nat Immunol. 2005;6:223–226. - PubMed
-
- Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, et al. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol. 2007;25:193–219. - PubMed
-
- Wang YH, Ito T, Wang YH, Homey B, Watanabe N, et al. Maintenance and polarization of human TH2 central memory T cells by thymic stromal lymphopoietin-activated dendritic cells. Immunity. 2006;24:827–838. - PubMed
-
- Liu YJ. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol. 2007;120:238–244. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
- M01 RR000096/RR/NCRR NIH HHS/United States
- R01 HL087679/HL/NHLBI NIH HHS/United States
- 1RL1MH083268-01/MH/NIMH NIH HHS/United States
- P30 ES000260/ES/NIEHS NIH HHS/United States
- G0500539/MRC_/Medical Research Council/United Kingdom
- R01ES10187/ES/NIEHS NIH HHS/United States
- N02-HL-6-4278/HL/NHLBI NIH HHS/United States
- N01-HC-25195/HC/NHLBI NIH HHS/United States
- R01 ES010187/ES/NIEHS NIH HHS/United States
- ES00260/ES/NIEHS NIH HHS/United States
- N01 HC025195/HL/NHLBI NIH HHS/United States
- M01RR00096/RR/NCRR NIH HHS/United States
- 5R01HL087679-02/HL/NHLBI NIH HHS/United States
- RL1 MH083268/MH/NIMH NIH HHS/United States
